News

FDA approves new twice-yearly HIV shot. What to know
The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...
AOL25d
FDA approves powerful HIV drug with the potential to end the ... - AOL
The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday.
BioSpace11d
Gilead Eyes HIV Market Domination With Twice-Yearly Yeztugo as GSK Trails
Analysts believe that Gilead's new PrEP drug Yeztugo could reach peak sales of $4.5 billion. Not if GSK has anything to say ...
NBC 10 Philadelphia24d
FDA approves powerful HIV prevention drug: What to know
FDA approves powerful HIV drug that nearly eliminated spread in clinical trials The twice-yearly injectable drug’s potential could be compromised by the Trump administration’s dramatic cuts to ...
New HIV prevention shot touted as breakthrough: HealthLink
HealthLink talked with a Seattle-based physician about why the newly approved drug could be a game-changer in preventing HIV.
The Pharma Letter12d
High costs and limited access threaten progress in HIV treatment despite new drug advances
Despite major strides in antiretroviral therapy (ART), the human immunodeficiency virus (HIV) market still faces serious ...
The Pharma Letter2d
Merck & Co’s NDA for HIV regimen accepted by FDA
The US Food and Drug Administration (FDA) has accepted for review Merck & Co’s New Drug Application (NDA) for ...
The Punch on MSN2d
712 children infected with HIV daily in 2024 -UNICEF
HIV estimates report published by the United Nations Children's Fund on Thursday revealed that of the estimated 40.8 million ...
FDA approves powerful HIV drug with the potential to end the epidemic in the U.S.
The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday.